Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? (Deficit) (Details Narrative)

v3.21.2
Stockholders’ (Deficit) (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
May 15, 2021
May 13, 2021
May 06, 2021
Jul. 21, 2021
Jul. 19, 2021
May 18, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Class of Stock [Line Items]                  
Capital stock authorized             260,000,000    
Common stock, authorized             250,000,000   250,000,000
Common stock, par value   $ 0.001   $ 0.001     $ 0.001   $ 0.001
Preferred stock, authorized             10,000,000   10,000,000
Preferred Stock, Par or Stated Value Per Share             $ 0.001   $ 0.001
Sale of common stock units     $ 1,162,790       $ 16,944,380  
Aggregate of shares   1,600,000   1,375,000          
Exercise price   $ 7.425   $ 6.15          
Offering price $ 6.75                
Underwriters agreed to purchase $ 1,600,000     $ 1,031,250          
Purchase additional shares 240,000                
Gross proceeds $ 10,800,000     $ 8,305,000 $ 50,000        
Representative, warrants to purchase             80,000    
Warrants are exercisable price             $ 7.425    
Net proceeds             $ 7,518,766    
Stock option exercise             6,592 455,390  
Stock option exercise             5,060    
Proceeds from common stock shares received               $ 3,381,271  
Share-based compensation expense for options             $ 120,252 $ 116,557  
Total unrecognized compensation expense             $ 354,344    
Weighted average period expected to recognized compensation expense (in years)             2 years 3 months 18 days    
Series A Preferred Stock Dividend Rate             10.00%    
Conversion of Stock, Shares Converted           1,401,786      
Accured unpaid dividends             $ 1,179,357    
Accrued dividends             $ 0    
Series A Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Conversion of Stock, Shares Converted           43,806